TGF-β: the master regulator of fibrosis

X Meng, DJ Nikolic-Paterson, HY Lan - Nature Reviews Nephrology, 2016 - nature.com
Transforming growth factor-β (TGF-β) is the primary factor that drives fibrosis in most, if not
all, forms of chronic kidney disease (CKD). Inhibition of the TGF-β isoform, TGF-β1, or its …

[HTML][HTML] TGF-beta as a master regulator of diabetic nephropathy

L Wang, HL Wang, TT Liu, HY Lan - International journal of molecular …, 2021 - mdpi.com
Diabetic nephropathy (DN) is one of the most common complications in diabetes mellitus
and the leading cause of end-stage renal disease. TGF-β is a pleiotropic cytokine and has …

[HTML][HTML] Diabetes and kidney disease: role of oxidative stress

C JhaJay, SM ChowBryna… - Antioxidants & redox …, 2016 - liebertpub.com
Significance: Intrarenal oxidative stress plays a critical role in the initiation and progression
of diabetic kidney disease (DKD). Enhanced oxidative stress results from overproduction of …

[HTML][HTML] Diabetic fibrosis

I Tuleta, NG Frangogiannis - … et Biophysica Acta (BBA)-Molecular Basis of …, 2021 - Elsevier
Diabetes-associated morbidity and mortality is predominantly due to complications of the
disease that may cause debilitating conditions, such as heart and renal failure, hepatic …

Transforming growth factor-β1 and diabetic nephropathy

AS Chang, CK Hathaway… - American Journal of …, 2016 - journals.physiology.org
Transforming growth factor-β1 (TGF-β1) is established to be involved in the pathogenesis of
diabetic nephropathy. The diabetic milieu enhances oxidative stress and induces the …

[HTML][HTML] Proteinuria in diabetic kidney disease: a mechanistic viewpoint

JA Jefferson, SJ Shankland, RH Pichler - Kidney international, 2008 - Elsevier
Proteinuria is the hallmark of diabetic kidney disease (DKD) and is an independent risk
factor for both renal disease progression, and cardiovascular disease. Although the …

TGF-β/Smad signaling in kidney disease

HY Lan, ACK Chung - Seminars in nephrology, 2012 - Elsevier
Chronic progressive kidney diseases typically are characterized by active renal fibrosis and
inflammation. Transforming growth factor-β1 (TGF-β1) is a key mediator in the development …

Сахарный диабет и хроническая болезнь почек

МВ Шестакова, ИИ Дедов - 2009 - elibrary.ru
В книге представлены современные данные об эпидемиологии, патогенезе,
профилактике и лечении различных вариантов поражения почек при сахарном …

Transforming growth factor-β/Smad signalling in diabetic nephropathy.

HY Lan - Clinical & Experimental Pharmacology & …, 2012 - search.ebscohost.com
Diabetic nephropathy (DN) is a major diabetic complication that is mediated by transforming
growth factor (TGF)-β1 via Smad-dependent and-independent signalling pathways., Under …

Therapeutic approaches to diabetic nephropathy—beyond the RAS

B Fernandez-Fernandez, A Ortiz… - Nature Reviews …, 2014 - nature.com
Despite improvements in glycaemic and blood pressure control, and the efficacy of renin–
angiotensin system (RAS) blockade for proteinuria reduction, diabetic nephropathy is the …